The manufacturer has moved to a four day working week and says it is now rebuilding market share following a challenging ...

Q4 2024 Earnings Call Transcript February 6, 2025 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.05 EPS, ...

AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...

Amazon faced ~900 Mn FX headwind in 4Q’24 which was ~700 mn higher than assumed. For the third consecutive quarter, AWS grew ...

The company plans to allocate a record amount to capital expenditures to build artificial-intelligence infrastructure.

A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday.

The Amazon company's revenue was just over the expectations, but its earnings-per-share were a substantial win.

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

Amazon reported $17.3 billion in advertising sales for Q4 2024, an increase of 18% -- which fell short of Wall Street ...

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.

Growing at a rate of knots from the Cambridge Biomedical Campus, AstraZeneca hoisted its market cap to £183.58 billion and ...